首页> 外文期刊>Indian journal of dermatology, venereology and leprology >Anaplastic lymphoma kinase-positive primary cutaneous anaplastic large cell lymphoma- Is it a new variant?
【24h】

Anaplastic lymphoma kinase-positive primary cutaneous anaplastic large cell lymphoma- Is it a new variant?

机译:间变性间变性淋巴瘤激酶阳性原发性皮肤间变性大细胞淋巴瘤-是否是新变异?

获取原文
获取原文并翻译 | 示例
           

摘要

Anaplastic large cell cutaneous lymphomas are clinically and pathologically heterogeneous, CD30 + (Ki-1) lymphoproliferative disorders. The importance of anaplastic lymphoma kinase (ALK) positivity is well known in the prognosis of primary systemic anaplastic large cell cutaneous lymphomas; however, the same in primary cutaneous anaplastic large cell cutaneous lymphomas is not much clear. Herein we report a 65-year-old male with an 18-month history of minimally pruritic localized nodulo-plaque lesion over lower back. Histology revealed cutaneous large cell lymphoma and immunohistochemical staining showed positivity for CD30, CD3 and ALK. The role of ALK positivity in pcALCL is discussed in this article.
机译:间变性大细胞皮肤淋巴瘤在临床和病理上是异质性的CD30 +(Ki-1)淋巴增生性疾病。间变性淋巴瘤激酶(ALK)阳性的重要性在原发性系统性间变性大细胞皮肤淋巴瘤的预后中是众所周知的。然而,在原发性皮肤间变性大细胞皮肤淋巴瘤中是否相同尚不清楚。在此,我们报告了一名65岁的男性,在下背部有最小的瘙痒性局限性结节性斑块病史,为18个月。组织学显示皮肤大细胞淋巴瘤,免疫组织化学染色显示CD30,CD3和ALK阳性。本文讨论了ALK阳性在pcALCL中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号